How Blood Thinners Appear To Help Coronavirus Patients In Severe State

Doctors in New York have found that providing blood thinning drugs could help COVID-19 patients increase their chances of surviving severe complications. The discovery offers a way to prevent blood clots throughout the body that make the disease harder to treat.

The new study, published in the Journal of the American College of Cardiology, suggests that providing blood thinners may help the patients who are already severely ill with the novel coronavirus. Researchers at Mount Sinai Hospital have started tests to see which anticoagulants provide more benefits and in what doses.

"The patients who received anticoagulants did better than those who didn't," Valentin Fuster, director of Mount Sinai Heart and physician-in-chief of the Mount Sinai Hospital, told CNN. "This has implications already. People, I believe, should treat these patients with antithrombotics."

Researchers first tested the blood thinning drugs with more than 2,700 patients with COVID-19 at Mount Sinai. The team said the treatment mainly worked on severe cases that required ventilators. 

Only 29 percent of patients on ventilators who received blood thinners died because of the coronavirus disease. Meanwhile, 63 percent of those on ventilators but did not take the drugs died. 

"Our findings suggest that systemic anticoagulants may be associated with improved outcomes among patients hospitalized with Covid-19," researchers said in the report. 

However, the team noted patients did not receive similar doses and types of blood thinners. Fuster said the study will continue to determine which drug and doses would deliver the best results. 

The next stage at Mount Sinai will focus on the classic blood thinner heparin and some newer oral anticoagulant drugs including dabigatran. Researchers also hope to analyze the effects of the drugs on COVID-19 patients with mild symptoms.

Doctors around the world have been reporting cases of COVID-19 that involved severe blood clotting. However, the medical community has yet to understand why the coronavirus causes the blood to clot.

"We have done 75 autopsies and clotting is a problem, without any question," Fuster said. "It starts with the lungs, followed by the kidneys, the heart and it ends up in the brain."

Blood thinners and COVID-19 A study in New York suggests that blood thinners could help improve the condition of patients who are already severely ill because of COVID-19. Pixabay

Join the Discussion